bpc 157 pancreas BPC157 drives angiogenesis through FBXO22-dependent stabilization of BACH1 | Cell Communication and Signaling A-H. Gross presentation of injury

The peptide exhibits consistent efficacy in models of acute and chronic injury regardless of administration route (intraperitoneal, oral, or local application), a unique characteristic distinguishing it from other growth factors that typically require localized delivery with carrier systems

So, you would need to inject 0.5 milliliters of the solution to deliver 500 mcg of vitamin B-12

Further positive outcome appears in the corticosteroid animals with severe burns (Mikus et al., 2001

The potential of these compounds is extraordinary

BPC-157 is not a controlled substance in Canada, and it is not approved for human use

Long-term data beyond 12 weeks in humans does not exist from controlled trials